¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nodular leprosy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nodular gliosis
    °áÀý½Å°æ¾Æ±³Áõ, °áÀý±³Áõ
  • nodular glomerulosclerosis
    °áÀýÅ丮±»À½Áõ, °áÀý»ç±¸Ã¼°æÈ­Áõ
  • nodular goiter
    °áÀý°©»ó»ùÁ¾
  • nodular hidradenoma
    °áÀý¶¡»ùÁ¾
  • nodular hyperplasia
    °áÀý°ú´ÙÇü¼º
  • nodular panniculitis
    °áÀýÁö¹æÃþ¿°
  • nodular prurigo
    °áÀý°¡·Á¿ò¹ßÁø
  • nodular salpingitis
    °áÀýÀڱðü¿°, °áÀý³­°ü¿°
  • nodular scabies
    °áÀý¿È
  • nodular scleritis
    °áÀý°ø¸·¿°
  • nodular sclerosis
    °áÀý°æÈ­
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • reactive nodular hyperplasia
    ¹ÝÀÀ¼º°áÀýÁõ½Ä
  • subepidermal nodular fibrosis
    Ç¥ÇǹذáÀý¼¶À¯Áõ
  • systemic nodular panniculitis
    Àü½Å°áÀýÁö¹æÃþ¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nodular fasciitis
    °áÀý±Ù¸·¿°
  • subepidermal nodular fibrosis
    Ç¥ÇǹذáÀý¼¶À¯Áõ
  • nodular gliosis
    °áÀý½Å°æ¾Æ±³Áõ
  • nodular glomerulosclerosis
    °áÀýÅ丮±»À½Áõ, °áÀý»ç±¸Ã¼°æÈ­Áõ
  • nodular goiter
    °áÀý°©»ó»ùÁ¾, °áÀý¹æÆÐ»ùÁ¾
  • nodular hidradenoma
    (¢¡clear cell hidradenoma) Åõ¸í¼¼Æ÷¶¡»ùÁ¾
  • nodular hyperplasia
    °áÀý°ú´ÙÇü¼º
  • reactive nodular hyperplasia
    ¹ÝÀÀ°áÀýÁõ½Ä
  • nodular lymphosarcoma
    °áÀý¸²ÇÁÀ°Á¾
  • nodular myolysis
    °áÀý±ÙÀ°¿ëÇØ
  • nodular panniculitis
    °áÀýÁö¹æÃþ¿°
  • nodular prurigo
    °áÀý°¡·Á¿ò¹ßÁø
  • nodular salpingitis
    °áÀýÀڱðü¿°
  • nodular scabies
    °áÀý¿È
  • nodular scleritis
    °áÀý°ø¸·¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • leprosy,lepromatous
    ³ªÁ¾¸ð¾ç(ÑÛðþÙ¼åÆ)
  • leprosy,tuberculoid
    °áÇÙ¸ð¾ç(Ì¿ú·Ù¼åÆ)
  • leprosy<³ª> lepra
    ³ª, ³ªº´(ÑÛÜ»).
  • leprosy<³ª> lepra
    ³ª, ³ªº´(ÑÛÜ»).
  • leprosy<³ª> lepra
    ³ªº´
  • macular leprosy
    ¹Ý»ó³ª(¡­ )
  • major tuberculoid leprosy
    ´ë°áÇپ糪(ÓÞÌ¿ ú·åÆÑÛ).
  • multibacillary leprosy
    ´Ù±Õ³ª
  • mutilating leprosy ³ª lepra mutilans
    Àý´Ü ³ª(ôîÓ¨ÑÛ)
  • neural leprosy
    ½Å°æ³ª.
  • neural leprosy
    ½Å°æ³ª(¡­³ª)
  • neural leprosy
    ½Å°æ³ª
  • paucibacillary leprosy
    Èñ±Õ¼º³ª
  • polar lepromatous leprosy
  • rat leprosy
    ÁãÀÇ ³ªº´(¡­ÑÛÜ»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NS   1) Nephrotic Syndrome
    1. Proteinuria
   &nb...
CNF chronic nodular fibrositis; congenital nephrotic syndrome of the Finnish [type]
CRNF chronic rheumatoid nodular fibrositis
FNH focal nodular hyperplasia
MCN maternal child nursing; minimal change nephropathy; mixed cell nodular [lymphoma]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NLH Nodular lymphoid hyperplasia
NM Nodular melanoma
NRH Nodular regenerative hyperplasia
PPNAD Primary pigmented nodular adrenocortical disease
NSHD nodular sclerosing Hodgkin disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nodular arteriosclerosis
    °áÀý¼º µ¿¸Æ°æÈ­Áõ
  • nodular density
    °áÀý¼º À½¿µ
  • nodular erythema
    °áÀý¼º È«¹ÝÁõ
    ³ÐÀû ´Ù¸®ÀÇ ¹Ù±ùÂÊ, ÆÈÀÇ ÇǺγ» ¶Ç´Â ÇÇÇÏ¿¡ °­³²Äá ¶Ç´Â »õ¾Ë¸¸ÇÑ Å©±âÀÇ ´ãÈ«»ö ȤÀº ¼±È«»öÀÇ °áÀýÀÌ »ý±â´Â ÇǺκ´. ¹ß¿­, °üÀýÅë µîÀÇ Àü±¸ Áõ»óÀÌ ÀÖ´Ù. ·ù¸ÓƼ¼º, °áÇÙ¼ºÀÇ °ÍÀÌ ¸¹´Ù.
  • nodular fashion
    °áÀý ÇüÅÂ
  • nodular lesion
    °áÀý¼º º´¼Ò
  • nodular pattern
    ¼Ò°áÀý ¾ç»ó
  • nodular swelling
    °áÀý¼º ºÎÁ¾
  • nodular thyroid
    °áÀý¼º °©»ó¼±
    °©»ó¼±ÀÇ Á¾´ë
  • nodular toxic goiter
    °áÀý¼º Áßµ¶¼º °©»ó¼±Á¾
  • subepidermal nodular fibrosis
    Ç¥ÇÇÇÏ °áÀý¼º ¼¶À¯Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
lazarine leprosy An acute form occurring in pure diffuse lepromatous leprosy presenting irregularly shaped, intensely erythematous, tender plaques, especially of the legs, with tendency to ulceration and scarring.
Synonym: lazarine leprosy, Lucio's leprosy phenomenon.
(05 Mar 2000)
lepromatous leprosy A form of leprosy in which nodular cutaneous lesions are infiltrated, have ill-defined borders, and are bacteriologically positive; the lepromin test is negative, i.e., the immunologic mechanism of the patient is not responsive to the Mycobacterium leprae infection.
(05 Mar 2000)
leprosy <infectious disease> Caused by Mycobacterium leprae, an obligate intracellular parasite that survives lysosomal enzyme attack by possessing a waxy coat.
Leprosy is a chronic disease associated with depressed cellular (but not humoral) immunity, the bacterium requires a lower temperature than 37­C and thrives particularly in peripheral Schwann cells and macrophages.
Only humans and the nine banded armadillo are susceptible.
(18 Nov 1997)
leprosy bacillus A species of gram-positive, aerobic bacteria that causes leprosy in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
(12 Dec 1998)
leprosy, borderline A form of leprosy in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
(12 Dec 1998)
leprosy, lepromatous A chronic communicable infection which is a principal or polar form of leprosy. This disorder is caused by mycobacterium leprae and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.
(12 Dec 1998)
leprosy test <investigation> A test for leprosy where an extract of infected tissue (antigen) is injected under the skin to determine if you have a current or recent leprosy infection.
Normally, little or no skin reaction should result from the injection. A positive skin reaction indicates a leprosy infection.
(27 Sep 1997)
leprosy, tuberculoid A principal or polar form of leprosy in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy (leprosy, lepromatous), the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others.
(12 Dec 1998)
Lucio's leprosy An acute form occurring in pure diffuse lepromatous leprosy presenting irregularly shaped, intensely erythematous, tender plaques, especially of the legs, with tendency to ulceration and scarring.
Synonym: lazarine leprosy, Lucio's leprosy phenomenon.
(05 Mar 2000)
Lucio's leprosy phenomenon An acute form occurring in pure diffuse lepromatous leprosy presenting irregularly shaped, intensely erythematous, tender plaques, especially of the legs, with tendency to ulceration and scarring.
Synonym: lazarine leprosy, Lucio's leprosy phenomenon.
(05 Mar 2000)
calcific nodular aortic stenosis Most common type of aortic stenosis, occurring usually in elderly men, in which the cusps contain calcified fibrous nodules on both surfaces; the causes include rheumatic fever, atherosclerosis, age-related degeneration, and congenitally bicuspid aortic valve.
(05 Mar 2000)
panniculitis, nodular nonsuppurative A form of panniculitis characterised by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders.
(12 Dec 1998)
goiter, nodular An enlarged thyroid gland containing circumscribed nodules within its substance.
(12 Dec 1998)
Salzmann's nodular corneal degeneration Large and prominent nodules of a solid, opaque material that stands out from the surface of the cornea; occurs occasionally in persons previously affected by phlyctenular keratitis.
(05 Mar 2000)
nodular Bumpy.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á